Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06160934 · ClinicalTrials.gov registry record · NA

The T1D Parent Check-In: A Preventative Intervention

A NA study of Type 1 Diabetes and Diabetes in Children, sponsored by Massachusetts General Hospital.

Active
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06160934: Active NA study of Type 1 Diabetes and Diabetes in Children, sponsored by Massachusetts General Hospital.

NCT06160934 is a NA study of Type 1 Diabetes and Diabetes in Children that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 50 participants, below the 766-participant average among 198 other Type 1 Diabetes trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06160934, a NA study of Type 1 Diabetes and Diabetes in Children, is active but no longer recruiting, sponsored by Massachusetts General Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to learn how to best support families during the first year of a child or teen's Type 1 diabetes (T1D) diagnosis. Specifically, we are testing a parenting intervention, the T1D Parent Check-in, designed for parents of children, ages 8 to 17 years, who have been newly diagnosed with T1D. This three-session intervention is delivered by diabetes psychologists over telehealth with the goal of helping families adjust to T1D, build resilience, and improve children's long-term health. For this trial, our main question is whether parents like the intervention and find it to be helpful and worth their time and effort. We also want to test whether participating in the intervention helps parents feel more confident in their parenting and problem-solving around diabetes, feel less worried about diabetes, reduce family conflict, and improve children's quality of life. To answer these questions, we will randomly assign study participants to one of two groups; parents will either 1) receive the T1D Parent Check-in intervention, or 2) receive their usual care through clinic. Parents assigned to the second group will have the option of participating in a one-time meeting with the psychologist at the end of the study to receive general information/resources from the study and receive feedback on their questionnaires. Parents in both groups will be asked to complete questionnaires four times over the course of six months. Parents will be paid to complete the questionnaires.

Primary Outcome

Recruitment data measured by percent of eligible families that were approached for participation that enrolled in study.

Interventions

  • BEHAVIORAL T1D Parent Check-in

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-02-01
Est. Completion 2026-06
Phase NA
Massachusetts General Hospital

2,032 total trials

What the registry record for NCT06160934 still lists

NCT06160934 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 766-participant average among 198 other Type 1 Diabetes trials with a reported enrollment target (93% lower).

The record links to 2 conditions, with Type 1 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which T1D Parent Check-in is the first listed.

NCT06160934 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06160934 about?

NCT06160934 is a clinical study titled "The T1D Parent Check-In: A Preventative Intervention". The goal of this clinical trial is to learn how to best support families during the first year of a child or teen's Type 1 diabetes (T1D) diagnosis. Specifically, we are testing a parenting intervention, the T1D Parent Check-in, designed for parents of children, ages 8 to 17 years, who have been new...

What is the current status of trial NCT06160934?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-02-01. Estimated completion is 2026-06.

What conditions does trial NCT06160934 study?

This clinical trial studies the following conditions: Type 1 Diabetes, Diabetes in Children.

What interventions are being tested in trial NCT06160934?

The interventions under investigation include: T1D Parent Check-in (BEHAVIORAL).

Who is sponsoring clinical trial NCT06160934?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06160934 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 1 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06160934's enrollment target sits among peer trials

50 87th of 198 higher than 107 of 198 other Type 1 Diabetes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Type 1 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06160934, the US trial registry maintained by the National Library of Medicine. NCT06160934 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.